Invention Application
- Patent Title: METHODS OF TREATING FGF21-ASSOCIATED DISORDERS
-
Application No.: US17539335Application Date: 2021-12-01
-
Publication No.: US20220162300A1Publication Date: 2022-05-26
- Inventor: Brian BOETTCHER , Shari Lynn CAPLAN , Regis CEBE , Guochun LI , John A. TARASZKA , Fangmin XU , David Langdon YOWE
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P3/00
Abstract:
The present invention relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human β-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
Public/Granted literature
- US11802152B2 Methods of treating FGF21-associated disorders Public/Granted day:2023-10-31
Information query
